Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc Closes Acquisition of DaVita HealthCare Partners Inc's Subsidiary HomeChoice Partners Inc


Monday, 4 Feb 2013 08:00am EST 

BioScrip Inc announced the February 1, 2013 closing of its previously announced agreement to acquire HomeChoice Partners Inc, provider of alternate-site infusion pharmacy services, for $70.0 million in cash. HomeChoice was a majority-owned subsidiary of DaVita HealthCare Partners Inc. 

Company Quote

8.29
0.03 +0.36%
22 Aug 2014